default author photo

Yihai Cao

Karolinska Institutet - Department of Microbiology, Tumor and Cell Biology (MTC)

Solnavägen 9

Solna, 171 65

Sweden

  • Karolinska Institutet - Department of Microbiology, Tumor and Cell Biology (MTC)

SCHOLARLY PAPERS

1

DOWNLOADS

53

TOTAL CITATIONS

0

Scholarly Papers (1)

Actions:
Email selected abstracts
1.

Cabozantinib, a Promising Therapeutic Strategy for Resistant Head and Neck Squamous Cell Carcinoma Patients

Number of pages: 164 Posted: 09 Aug 2021
Anais Hagege, Olivia Rastoin, Damien Ambrosetti, Julien Boyer, Xingkang He, Julie Rousset, Christopher Montemagno, Julien Parola, Isabelle Bourget, Frederic Luciano, Esma Saada-Bouzid, Alexandre Bozec, Yihai Cao, Gilles Pagès and Maeva Dufies
Université Côte d'Azur - Institute for Research on Cancer and Aging of Nice (IRCAN), Université Côte d'Azur - Institute for Research on Cancer and Aging of Nice (IRCAN), Université Cote d'Azur - Central laboratory of Pathology, Centre Antoine Lacassagne, Karolinska Institutet - Department of Microbiology, Tumor and Cell Biology (MTC), Centre Antoine Lacassagne, Université Côte d'Azur - Institute for Research on Cancer and Aging of Nice (IRCAN), Université Côte d'Azur - Institute for Research on Cancer and Aging of Nice (IRCAN), Université Côte d'Azur - Institute for Research on Cancer and Aging of Nice (IRCAN), Université Côte d'Azur - Institute for Research on Cancer and Aging of Nice (IRCAN), Centre Antoine Lacassagne, Centre Antoine Lacassagne, Karolinska Institutet - Department of Microbiology, Tumor and Cell Biology (MTC), Université Côte d'Azur - Institute for Research on Cancer and Aging of Nice (IRCAN) and Université Côte d'Azur - Institute for Research on Cancer and Aging of Nice (IRCAN)
Downloads 53 (1,031,043)

Abstract:

Loading...

AXL, c-MET, head and neck squamous cell carcinoma (HNSCC), radiotherapy, cisplatin, resistance, cabozantinib, anti-angiogenic, VEGFR inhibitor, therapy repositioning